Project Details
| Status | Active |
|---|---|
| Effective start/end date | 2/16/22 → 2/16/25 |
Funding
- Pharmaceutical Research Associates, Inc. (Prot#MGL-3196-18 // Prot#MGL-3196-18)
- Synta Pharmaceuticals Corp. (Prot#MGL-3196-18 // Prot#MGL-3196-18)
Prot#MGL-3196-18: A 52-Week, Phase 3 Open-Label Extension Study, with a Single-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAEST
- Cheung, Amanda Ching-Wun (PD/PI)
- Flamm, Steven L (PD/PI)
- Kulik, Laura M (PD/PI)
- Rinella, Mary Eugenia (PD/PI)
Project: Research project